Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA) Meeting Abstract
| Authors: | Ku, G.; Elimova, E.; Denlinger, C. S.; Mehta, R.; Lee, K. W.; Iqbal, S.; Kang, Y. K.; Oh, D. Y.; Rha, S. Y.; Kim, Y. H.; Seol, Y. M.; Mwatha, T.; Grim, J.; Ajani, J. A. |
| Abstract Title: | Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA) |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S1044 |
| End Page: | S1045 |
| Language: | English |
| ACCESSION: | WOS:000700527702393 |
| DOI: | 10.1016/j.annonc.2021.08.1489 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1380P -- Source: Wos |
